Hematopoietic Cell Transplantation for Thalassemia: A Global Perspective BMT Tandem Meeting 2013

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1 SUPPL., 2013, Pages

  Mehta, Parinda A ^a   Faulkner, Lawrence B ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Cure2Children Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; FENLEUTON; FLUDARABINE; THYMOCYTE ANTIBODY; TREOSULFAN;

ARTICLE; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EVENT FREE SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HEPATOSPLENOMEGALY; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL COOPERATION; IRON OVERLOAD; LIVER BIOPSY; LIVER VENOOCCLUSIVE DISEASE; MEDICAL EDUCATION; OVERALL SURVIVAL; PATIENT COMPLIANCE; RISK ASSESSMENT; SPLENECTOMY; THALASSEMIA MAJOR;

BETA-THALASSEMIA; CONGRESSES AS TOPIC; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, SPECIAL; HUMANS; LONGEVITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84871903577     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.10.025     Document Type: Article

References (24)

1. Weatherall D.J. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115:4331-4336.
2. Thomas E.D., Buckner C.D., Sanders J.E., et al. Marrow transplantation for thalassemia. Lancet 1982, 320:227-229.
3. Angelica E. Hematopoietic stem cell transplantation in thalassemia. Hematology Am Soc Hematol Educ Program 2010, 2010:456-462.
4. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Eng J Med 1990, 322:417-421.
5. Mathews V., George B., Deotare U., et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with β-thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:889-894.
6. Sabloff M., Chandy M., Wang Z., et al. HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood 2011, 117:1745-1750.
7. Mathews V., George B., Lakshmi K.M., et al. Impact of pretransplant splenectomy on patients with β-thalassemia major undergoing a matched-related allogeneic stem cell transplantation. Pediatr Transplant 2009, 13:171-176.
8. Akhtar S., Moatter T. Hepatitis C virus infection in polytransfused thalassemic children in Pakistan. Indian Pediatr 2004, 41:1072-1073.
9. Borgna-Pignatti C., Vergine G., Lombardo T., et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004, 124:114-117.
10. Erer B., Angelucci E., Lucarelli G., et al. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 14:369-372.
11. Angelucci E., Muretto P., Nicolucci A., et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100:17-21.
12. Gaziev J., Sodani P., Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone Marrow Transplant 2008, 42(suppl 1):S41.
13. Sodani P., Gaziev D., Polchi P., et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004, 104:1201-1203.
14. Russell J.A., Tran H.T., Quinlan D., et al. Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes. Biol Blood Marrow Transplant 2002, 8:468-476.
15. Bernardo M.E., Zecca M., Piras E., et al. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br J Haematol 2008, 143:548-551.
16. Chandy M., Balasubramanian P., Ramachandran S.V., et al. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia: the role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant 2005, 36:839-845.
17. Faulkner L., Yaqub N., Khalid S.K., et al. Transplantation in low resource countries. Thalassemia Rep 2012, 1(s2):e9.
18. Klein T., Yaniv I., Stein J., et al. Extended family studies for the identification of allogeneic stem cell transplant donors in Jewish and Arabic patients in Israel. Pediatr Transplant 2005, 9:52-55.
19. La Nasa G., Giardini C., Argiolu F., et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002, 99:4350-4356.
20. Ruggeri A., Eapen M., Scaravadou A., et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011, 17:1375-1382.
21. + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood 2010, 115:1296-1302.
22. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation after reduced-intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011, 118:282-288.
23. Marziali M., Isgrò A., Gaziev J., et al. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia: single-center experience in a multiracial population. Medit J Hematol Infect Dis 2009, 1:e2009027.
24. Ahmed S., Saleem M., Modell B., et al. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 2002, 347:1162-1168.